Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome

This publication has 43 references indexed in Scilit:

• Thrombomodulin Mutations in Atypical Hemolytic–Uremic Syndrome
  New England Journal of Medicine, 2009
• Recurrent Atypical Hemolytic Uremic Syndrome Associated With Factor I Mutation in a Living Related Renal Transplant Recipient
  American Journal of Kidney Diseases, 2009
• Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome
  Blood, 2008
• The Complement Factor H R1210C Mutation Is Associated With Atypical Hemolytic Uremic Syndrome
  Journal of the American Society of Nephrology, 2008
• Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome
  Blood, 2008
• Deletion of Complement Factor H–Related Genes CFHR1 and CFHR3 Is Associated with Atypical Hemolytic Uremic Syndrome
  PLoS Genetics, 2007
• A missense mutation in factor I (IF) predisposes to atypical haemolytic uraemic syndrome
  Pediatric Nephrology, 2007
• Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome
  Proceedings of the National Academy of Sciences, 2007
• Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome
  Blood, 2006
• CHARMM: A program for macromolecular energy, minimization, and dynamics calculations
  Journal of Computational Chemistry, 1983